This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Medibank Private seeks legal action to halt Australian privacy watchdog's probe into 2022 data breach

By Saloni Sinha ( October 5, 2023, 03:42 GMT | Insight) -- Medibank Private has moved ahead with its attempt to shut down an inquiry by the country’s privacy watchdog into a massive 2022 data breach, with court documents revealing that the health insurer wants to ensure that the probe doesn’t interfere with ongoing class-action lawsuits. In court documents seen by MLex, Medibank has sought to restrain the Office of Australian Information Commissioner from finalizing its investigation into the data breach incident that affected 10 million consumers based on a representative complaint.Medibank Private has moved ahead with its attempt to shut down an inquiry by the country’s privacy watchdog into a massive 2022 data breach, with court documents revealing that the health insurer wants to ensure that the probe doesn’t interfere with ongoing class-action lawsuits....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections